Skip to content
PubMed This is a summary of 45 peer-reviewed journal articles Updated
Gynecology · Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 2

Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome Type 2 Resource Guide

At a Glance

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 2 is a rare congenital condition affecting the reproductive system, kidneys, and spine. While it involves an underdeveloped or absent vagina and uterus, a multidisciplinary care team can help manage symptoms and support future family planning.

A diagnosis of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 2 is a major life event. It is a rare, congenital condition that affects both the reproductive system and other bodily systems, such as the kidneys and spine. The discovery of MRKH often brings up intense emotions and a lot of questions about your health, your identity, and your future.

This guide was designed to empower you and your family with clear, evidence-based information. We break down the biology of MRKH Type 2, explain how to navigate the medical system, and outline your options for treatment and family planning when you are ready.

Use the links below to navigate through the topics that matter most to you right now.

Table of Contents

Common questions in this guide

What is MRKH syndrome type 2?
MRKH type 2 is a rare congenital condition where the vagina and uterus are underdeveloped or absent. Unlike MRKH type 1, type 2 also involves differences in other body systems, most commonly the kidneys and the spine.
How does MRKH type 2 affect the kidneys and spine?
Patients with MRKH type 2 may have structural differences in their skeletal and renal systems. This can include spinal curvature or missing and malformed kidneys, requiring regular screening and monitoring by a specialized care team.
Can I have biological children if I have MRKH type 2?
Yes, many people with MRKH type 2 can have biological children. Because the ovaries typically function normally, eggs can be retrieved for in vitro fertilization (IVF) and carried by a gestational surrogate.
How is vaginal agenesis treated in MRKH?
Vaginal agenesis is typically treated when the patient is ready. Options include non-surgical vaginal dilation methods or surgical procedures to create a vaginal canal, depending on what your medical team determines is best for your specific body.

This guide is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or a specialist regarding MRKH type 2 diagnosis, screening, and treatment options.

Get notified when new evidence is published on Mayer-Rokitansky-Küster-Hauser syndrome type 2.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.